Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$1.1B
Avg Funding
$42.9M
Global Reach
8
countries

Top Cities for Biopharma

São Paulo
Emeryville
Villa Lynch
Palo Alto
Boston
Recoleta

Recently Funded Companies

Export
São Paulo, Brazil

Dematerializing hygiene, health and well-being products

$27K raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Emeryville, United States

PhenomeX is a provider of life sciences that have the era of the phenome as the next revolution in biology and medicine unfolds.

$70.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Villa Lynch, Argentina

Eureka Nanobioengineering offers a proprietary platform for the creation of nanobiodevices and advanced functional nanobiomaterials.

$250K raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

$33.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Boston, United States

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

$63.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Recoleta, Argentina

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

$8.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Paris, France

Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.

$4.9M raised
Nov 2023

Founder Contacts

30,000+ verified contacts

Gaithersburg, United States

Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.

$10.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Dundee, United Kingdom

Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.

$2.2M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

Nanobots Therapeutics is a deeptech firm focused on the development and commercialization of the MotionTx platform.

$1.0M raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Lakewood, United States

Khona Scientific is a biotechnology company that focuses on a proprietary method of biosynthesis production.

$2.1M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Aurora, United States

Vona Oncology is a biotechnology company that develops cancer-treatment medications.

$250K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

$30.0M raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Perth, Australia

Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory diseases.

$649K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Calgary, Canada

NuVessl is a nanotechnology company that specializes in pharmaceutical, product development, and research development.

$657K raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Gwynedd, United States

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

$35.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

$115.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Belmont, United States

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.

$120.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Redwood City, United States

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

$200.0M raised
Nov 2023

Founder Contacts

30,000+ verified contacts

Columbus, United States

Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.

$40.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Needham, United States

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

$90.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

London, United Kingdom

SynbiCITE is a pioneering Innovation & Knowledge Centre dedicated to promoting the adoption and use of synthetic biology by industry.

$3.8M raised
Nov 2024

Founder Contacts

30,000+ verified contacts

New York, United States

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

$215.0M raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Closter, United States

Chemo Mouthpiece is an medical device company that develops and commercializes propriety oral cryotherapy products for cancer patients.

$900K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

$24.6M raised
Nov 2023

Founder Contacts

30,000+ verified contacts

Showing 751 to 775 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$42.9M
Total Funding Tracked
$1.1B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
2 companies$139.6M
2.São Paulo
1 companies$27K
3.Emeryville
1 companies$70.0M
4.Villa Lynch
1 companies$250K
5.Palo Alto
1 companies$33.5M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 31 | VCBacked